Introduction
The mammalian protein kinase A (PKA) family consists of four regulatory and three catalytic subunits, and each subunit is encoded by a unique gene. Cyclic-AMP dependent protein kinase (cPKA), a serine-threonine kinase, is involved in a wide range of cellular functions such as metabolism, transport, cell cycle, and gene regulation. Furthermore, cPKA is involved in controlling hippocampal neuronal activity, [1] [2] [3] [4] and has been reported to participate in maintaining epileptic activity and inducing status epilepticus. [5] [6] [7] [8] [9] [10] For instance, in tottering mice 5 or genetically prone to audiogenic seizures (GPAS) rats, 6 the abnormal elevation of PKA activity has been demonstrated to contribute to a functional impairment of GABA A receptor, and be involved in mechanisms of genetic predisposition to spontaneous seizures. In status epilepticus (SE) model, Niimura et al. 7 observed that phosphorylation of NR1 by PKA was depressed relative to controls immediately following SE and transiently increased above control values upon the termination of SE. Vá zquez-Ló pez et al. 8 suggested that acute picrotoxin-induced seizures occurred without an increase in PKA activity in the hippocampus, but reduced PKA-mediated phosphorylation protected against picrotoxin seizures by increasing the inhibitory potential of GABA A receptors. In hippocampal interneurons, it has been shown that H2 histamine receptor activation negatively modulates outward currents through Kv 3.2 -containing potassium channels by a mechanism involving PKA phosphorylation and PKA phosphorylation of Kv 3.2 lowered the maximum firing frequency of inhibitory neurons, which in turn negatively modulated highfrequency population oscillations recorded in principal cell layers. 11 However, so far, there is no study to describe detailed localization of cPKA in the hippocampus, particularly in different subtypes of calcium binding protein (CBP) (calbindin, CB; calretinin, CR; parvalbumin, PV) immunopositive interneurons. Furthermore, the progressive changes of cPKA in the hippocampus at acute stages, i.e., within 1 day, during and after pilocarpine induced status epilepticus are also unknown. Therefore, the present study was carried out to address these issues in order to provide clues for better understanding the roles that cPKA might play in inducing or maintaining status epilepticus, and in neurodegenerative changes at acute stages during and after pilocarpine induced status epilepticus.
Materials and methods

Video camera and electroencephalography (EEG) monitoring
To monitor EEG of the freely moving mice, a transmitter (TSE, Bad Homburg, Germany) was fixed on the electrode socket by plug connection with wires attached to the skull of mice by two screws (2.3 mm posterior and 2 mm lateral to bregma) 3 days before pilocarpine induction. The EEG signals were telemetrically received via HF receiver which passed the signals to the computer. The duration of EEG monitoring was 24 h starting from 30 min before injection of methyl-scopolamine nitrate. Special telemetry interfaces built in the computer decoded and processed the signals from the receiver and then transferred them to the personal computer. Signals were then read by the TSE TeleSys data acquisition and analysis program. Video camera recording was done simultaneously, so to correlate behavioral changes to EEG data.
Pilocarpine treatment
B29 male and female mice weighing 25-30 g were used for the study according to our established procedure. 12, 13 Mice were given a single subcutaneous injection of methyl-scopolamine nitrate (1 mg/kg) 30 min before the injection of either saline in the control or pilocarpine in the experimental groups. In the latter group, the mice received a single i.p. injection of 300 mg/kg pilocarpine and experienced acute SE. In this experiment, 9% animals died during and after induction. Therefore, they were not included in the quantitative study. All experiments were approved by the Tan Tock Seng Hospital -National Neuroscience Institute Institutional Animal Care and Use Committee. In the handling and care of all animals, the guidelines of the NIH for animal research were strictly followed. Efforts were made throughout the study to minimize animal suffering and to use the minimum number of animals.
Immunohistochemical study of the expression of cPKAb and cPKAg
A total of 24 mice was used for immunohistochemical study. Six mice were killed at each of the survival intervals after beginning of the status epilepticus, i.e. at 30 min, 2 h during pilocarpine induced status epilepticus, and at 1 day after pilocarpine induced status epilepticus. Six mice with saline instead of pilocarpine injection were killed at 30 min, 2 h and 1 day for the control group. Following deep anaesthesia with chloral hydrate (0.4 g/kg), the mice were perfused transcardially with 100 ml of saline initially, followed by 100 ml of 4% paraformaldehyde in 0.1 M PB (phosphate buffer, pH 7.4) for 15 min. After perfusion, the brain of each mouse was removed, and kept overnight in 30% sucrose in 0.1 M phosphate buffer. Coronal sections at 40 mm thickness were cut in a cryostat (HM505E, Microm; Zeiss, Oberkochen, Germany). Serial sections were transferred to different wells of a 24-well tissue culture dish for controls and PKA immunohistochemical reaction. For immunohistochemical study, free-floating sections were treated with 2% lyophilized bovine serum albumin in TBS-TX (Tris-buffered saline with 1% Triton X-100, PH 7.6) (for cPKAb and cPKAg) for 2 h at room temperature. All sections were then washed in TBS-TX and placed overnight at room temperature in the primary goat antibodies against cPKAb (1:500 in TBS-TX) and cPKAg (1:1000 in TBS-TX) (Santa Cruz Biotechnology, CA, USA). After incubation, sections were washed in TBS-TX and placed for 2 h in biotinylated anti-goat IgG secondary antibodies (1:400 in TBS-TX). After three washes in TBS-TX, the sections were placed in avidin-biotin complex (ABC) reagent (Vector Laboratories, Burlingame, CA, USA, 1:100 in TBS-TX) for 2 h. They were then washed in 0.1 M Tris buffer (TB, pH 7.6) and reacted in a solution of 0.012% H 2 O 2 and 0.05% 3,3 0 -diaminobenzidine (Sigma, St. Louis, MO, USA) in TB for 3-5 min and washed in TB, mounted, dehydrated and covered. In the negative control section, the primary antibodies were omitted.
Double-labeling immunofluoresence microscopy
Double-labeling immunofluoresence microscopy was carried out to co-localize cPKAb and cPKAg with different subtypes of calcium binding protein (calbindin, calretinin and parvalbumin from Chemicon International Inc., CA, USA) in hippocampal neurons. For this study, tissue sections from six control mice were washed in 0.1 M TBS-TX and placed overnight in primary antibodies (cPKAb: 1:500, cPKAg: 1:1000, calbindin: 1:2000, calretinin: 1:1500, parvalbumin: 1:1500). After incubation, sections were washed in TBS-TX and placed for 4-6 h in Cy3-conjugated donkey anti-goat IgG (1:200, Chemicon International Inc., CA, USA), followed by incubation with FITC-conjugated goat anti-mouse IgG (1:200, Chemicon International Inc., CA, USA) for 4-5 h. The sections were then mounted, dried, and covered with FluorSave TM Reagent (Calbiochem, San Diego, CA, USA) to retard fading, and examined with an Olympus Fluoview FV500 (Olympus Corporation, Tokyo, Japan) confocal laser scanning biological microscope.
Cell counting and statistical analysis
Cell counting was carried out using the Image-Pro Plus system (Media Cybernetics, Silver Spring, MD, USA). The cPKAb and cPKAg immunopositive neuronal profiles (defined by neuroanatomical and morphological characteristics without evidence of co-localization with neuronal marker) in the strata oriens, radiatum, lacunosum moleculare, granulosum and in the hilus of the dentate gyrus were counted and indicated as a number per square millimeter. In the stratum pyramidale of CA1, the intensity value was measured and was normalized to the intensity value of corpus callosum. 3-5 sections (the intersection distance is 40 mm Â 8 mm = 320 mm) of the dorsal hippocampus from each animal were used for cell counting or intensity measurement. Immunofluorescent neurons were counted under the confocal microscope, and the ratios of the number of double-labeled neurons to all the calbindin-, calretinin-or parvalbumin labeled neurons were obtained. For every section (3-5 sections for every animal), all calbindin, calretinin or parvalbumin immunopositive cells in the respective areas were counted. To avoid the false immunopositive cell counting, double-labeled cells were confirmed under high magnification (400Â) with two different filters. Each cell was also tilted at two vertical planes in order to confirm that the yellow color was produced by the red and green labeling in the same cell instead of two overlapped cells with different colors. All the data were then subjected to statistical analysis by one-way ANOVA followed by Student-Newman-Keuls posthoc multiple comparisons.
Results
Behavioral and EEG monitoring
In the mouse model, pilocarpine-induced behavioral changes include hypoactivity, tremor, head bobbing, and myoclonic movements of the limbs progressing to recurrent myoclonic convulsions with rearing, falling, and status epilepticus. The onset of continuous epileptic spiking activity, which was considered to be a marker for the onset of status epilepticus, was found at 28.72 AE 10.84 min after pilocarpine injection. The continuous epileptic spiking activity (>0.5 Hz) lasted for about 7.23 AE 1.59 h.
cPKAb and cPKAg in the hippocampus of the control mice
In mouse hippocampus, moderately to strongly stained cPKAb (Figs. 1A and 2A) or cPKAg (Figs. 1B and 2E) immunopositive neurons were found in the strata oriens, radiatum and lacunosum moleculare of the CA1-3 area, and in the hilus of the dentate gyrus (Fig. 3A for cPKAb and E for cPKAg). cPKAb immunopositive neurons were also demonstrated in the stratum pyramidale of CA1-3 area and the stratum granulosum of the dentate gyrus (Fig. 1A, 2A and 3A) . Moderately stained cPKAb immunopositive product was also localized in the stratum lucidum of CA3 area where mossy fibers and terminals were located (Fig. 1A) . Strong cPKAg immunopositive product appeared in the molecular layer and hilus of the dentate gyrus and in the stratum lucidum of CA3 area (Fig. 1B) .
[ ( F i g . _ 1 ) T D $ F I G ] Fig. 1. Immunocytochemical staining shows cPKAb (A) and cPKAg (B) immunopositive product in the hippocampus of the control mice. Moderate cPKAb immunopositive product is localized in the stratum pyramidale (SP) of CA1-3 areas and in the stratum granulosum (SG) of the dentate gyrus. Weak cPKAb immunopositive product is located in the stratum lucidum of CA3 area (arrows). Moderately to strongly stained cPKAg (B) immunopositive product is localized in the hilus and molecular layer (asterisks) of the dentate gyrus and in the stratum lucidum (arrows) of CA3 area. Scale bar = 200 mm, also applies to (A).
[ ( F i g . _ 2 ) T D $ F I G ] Fig. 2A) , the number of cPKAb immunopositive neurons reduced significantly at both 30 min (Fig. 2B) (P < 0.05, Fig. 4D ) and 2 h during pilocarpine induced status epilepticus (Fig. 2C) (P < 0.01, Fig. 4D ), but returned back at 1 day after pilocarpine induced status epilepticus ( Fig. 2D, P > 0.05, Fig. 4D ). At all the time points, cPKAg immunopositive product was almost undetectable in the stratum pyramidale of CA1 area (Fig. 2E-H) .
3.3.1.2. Strata oriens and radiatum. At 30 min (Fig. 2B ) and 2 h (Fig. 2C ) during pilocarpine induced status epilepticus, the number of cPKAb immunopositive neurons also decreased significantly compared with the control (Fig. 2A) (P < 0.01, Fig. 4A and B) , but it was similar to the control at 1 day after pilocarpine induced status epilepticus (Fig. 2D ) (P > 0.05, Fig. 4A and B) . In the two layers, the number of cPKAg immunopositive neurons reduced significantly at 30 min (Fig. 2F ), 2 h during (Fig. 2G ) and 1 day after pilocarpine induced status epilepticus (Fig. 2H ) compared to the control (Fig. 2E) (P < 0.05, Fig. 4A and B) . However, no significant difference was shown for PKAg immunopositive neurons among 30 min, 2 h during and 1 day after pilocarpine induced status epilepticus (P > 0.05, Fig. 4A and B) . Fig. 2D and H) pilocarpine induced status epilepticus, the number of both cPKAb (Fig. 2B-D) and cPKAg ( Fig. 2F-H) immunopositive neurons in the stratum lacunosum moleculare of CA1 area did not change significantly compared to the control (cPKAb: Fig. 2A; cPKAg: Fig. 2E ).
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Dentate gyrus
3.3.2.1. Stratum granulosum. cPKAb immunopositive product in the stratum granulosum at 30 min (Fig. 3B ), 2 h during (Fig. 3C ) and 1 day after (Fig. 3D ) pilocarpine induced status epilepticus was similar to the control mice (Fig. 3A) . No obvious change of cPKAg immunopositive product was observed in this layer among different groups of mice (control: Fig. 3E ; 30 min: Fig. 3F ; 2 h: Fig. 3G; 1 day: Fig. 3H ).
Hilus
In the hilus of the dentate gyrus, drastic reduction of both cPKAb or PKAg immunopositive neurons occurred at 30 min (cPKAb: Fig. 3B ; cPKAg: Fig. 3F ) and 2 h during (cPKAb: Fig. 3C ; cPKAg: Fig. 3G ) and 1 day after (cPKAb: Fig. 3D ; cPKAg: Fig. 3H ) pilocarpine induced status epilepticus compared to the control mice (cPKAb: Fig. 3A ; cPKAg: Fig. 3E ) (P < 0.01/0.05, Fig. 4C ).
Double-labeling immunofluorescence microscopy
In CA1 area of the hippocampus in the control mice, most of calbindin (CB; Fig. 5A ) or parvalbumin (PV; Fig. 5C ) immunopositive neurons were cPKAb (Fig. 5A-C) immunopositive, only 40.8% of CR (CR; Fig. 5B ) immunopositive neurons were cPKAb immunopositive. Most PV (Fig. 5F ) immunopositive neurons expressed cPKAg (Fig. 5D-F) , while 49.5% CB (Fig. 5D ) immunopositive neurons and 28.8% CR (Fig. 5E ) immunopositive neurons were cPKAg positive (Table 1) .
In the dentate gyrus, cPKAb was co-localized with CB in the stratum granulosum (Fig. 5G) . However, there was no colocalization of cPKAg with CB (Fig. 5J) . In the hilus of the dentate gyrus, about 79.5% and 79.3% of CR immunopositive neurons expressed cPKAb (Fig. 5H) and cPKAg (Fig. 5K) respectively. Almost all the PV immunopositive neurons were cPKAb immunopositive in the hilus and the stratum granulosum of the dentate gyrus (Fig. 5I) . However, only 56.3% of PV immunopositive neurons were cPKAg immunopositive (Fig. 5J-L In situ hybridization has shown that the mRNA expression pattern of cPKAa varied from that of cPKAb in the hippocampus. mRNA encoding cPKAa was equally distributed between the dentate gyrus and pyramidal cell layers CAl-3. In contrast, although cPKAb expression was high in the dentate gyrus, little cPKAb mRNA was observed in the CAl-3 cell layers. 22 It is inconsistent with our study showing moderately to strongly expressed cPKAb protein in the stratum pyramidale of CA1-3, suggesting that gene and protein expressions may not be always matched. In subcellular elements of cultured hippocampal neurons, cPKA was co-localized with microtubules in dendrites as well as with the actin filaments in growth cones, which indicated that PKA was anchored to actin and MT cytoskeletons. 23 However, so far, there is still no systemic study of the localization of cPKA proteins in different areas of hippocampus and different types of hippocampal neurons. In the present study, we showed that cPKAb was expressed by hippocampal principal and hilar cells, interneurons, and mossy fibers, cPKAg was localized in hippocampal interneurons, hilar cells, mossy fibers and molecular layer of the dentate gyrus. The study therefore provides first neuroanatomical basis for understanding the mechanism of not only functional changes of hippocampal principal cells and interneurons regulated by cPKA, 1,2 but also the selective defect in mossy fiber LTP after ablation of gene targeting on cPKA 24 as cPKAb is localized in mossy fibers and terminals in the stratum lucidum of CA3 area. Double-labeling immunohistochemistry revealed that most of PV immunopositive neurons expressed cPKAb or cPKAg in CA1 area and in the dentate gyrus, and most of CR immunopositive neurons in the hilus of the dentate gyrus were cPKAb or cPKAg immunopositive. It therefore suggests that cPKA may play a very important role in regulation of the activity of PV interneurons (basket cells) which innervate the perisomatic area of principal cells and hilar mossy cells labeled by CR.
Progressive changes of cPKA in hippocampal neurons during and after pilocarpine induced status epilepticus
Bracey et al. 25 demonstrated an increase in PKA activity in cortical structures, but not in hippocampus at later stages after pilocarpine induced status epilepticus. The present study may therefore provide some clues for better understanding the mechanism of PKA-related neuronal excitability and epileptogenesis during and after status epilepticus. It has been reported that cPKA inhibits the function of brain GABA A receptors, 14 and is involved in GABA A receptor dysfunction in CA1 pyramidal neurons following chronic benzodiazepine treatment. 15 PKA phosphorylation of Kv3.2-containing potassium channels in inhibitory interneurons is also involved in H2 histamine receptor modulated outward currents, which lowered the maximum firing frequency of inhibitory neurons, and in turn negatively modulated high-frequency population oscillations recorded in principal cell layers. 11 In tottering mouse brain, an abnormal elevation of PKA activity contributes to an impairment of GABA A receptor function which may play a role in induction of the seizures. 5 However, reduced PKA-mediated phosphorylation protects against picrotoxin seizures by increasing the inhibitory potential of GABA A receptors. 8 In the present study 30 min and 2 h during pilocarpine induced status epilepticus, fewer cPKAb immunopositive principal cells and cPKAb or cPKAg immunopositive interneurons in CA1 area, and fewer cPKAb or cPKAg immunopositive hilar neurons in the dentate gyrus were observed, which in fact was not caused by neuronal loss, 26 suggesting a down-regulation of cPKA may reflect a compensatory mechanism to reduce impairment of GABA A receptor function in the hippocampus. In the hilus of the dentate gyrus, significant reduction of cPKAb or cPKAg immunopositive neurons at 1 day after pilocarpine induced status epilepticus may be due to the loss of hilar neurons which has been reported previously.
27,28
Many of previous studies suggested that cAMP/PKA signaling could modulate excitatory synaptic transmission in the hippocampus. Activating cAMP/PKA signaling pathway enhanced whole-cell current responses to glutamate, and these responses were blocked by a specific peptide inhibitor of PKA. 29 Also, SpcAMPS, a phosphodiesterase-resistant activator of PKA, was demonstrated to potentiate glutamatergic receptor currents in cultured hippocampal neurons. 16 Furthermore, single-channel activity monitored in the presence of purified cPKA also showed that these subunits increased opening frequency and mean open time of glutamate receptor channels. 29 Hence, the down-regulation of PKAb in principal cell of CA1 area at early stage during pilocarpine induced status epilepticus may reduce the presynaptic glutamate release and decreases phosphorylation on serine and threonine residues of GABA A receptors, which keep GABA receptors consistently below their full inhibitory potential 30 leading to the hyperexcitability of CA1 pyramidal neurons. In the hilus of the dentate gyrus, as most of CR (which is a marker for hilar mossy cells) immunopositive neurons were cPKAb or cPKAg immunopositive, down-regulation of cPKAb or cPKAg at 30 min and 2 h during pilocarpine induced status epilepticus may reflect a compensatory neuroprotective mechanism to prevent the loss of mossy cells in the dentate gyrus.
In the present study, the quantitative study of protein expression of cPKA has been explored only in dorsal hippocampus instead of the whole hippocampus. Further study may be needed to show if similar changes occur in the ventral hippocampus.
